Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes

Drug Metabolism and Disposition

Volumn 30, Issue 4, 2002, Pages 421-429

  Acheampong, Andrew A ^a   Shackleton, Martha ^a   John, Brian ^a   Burke, James ^b   Wheeler, Larry ^a   Tang Liu, Diane ^a  

^a ALLERGAN INC   (United States)

^b HUNTINGDON LIFE SCIENCES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CARBON 14;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID; CILIARY BODY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IRIS; MALE; MASS SPECTROMETRY; MONKEY; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; RABBIT; RAT; RETINA; VITREOUS BODY;

ADMINISTRATION, TOPICAL; ANIMALS; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EYE; INJECTIONS, INTRAPERITONEAL; IRIS; MACACA FASCICULARIS; METABOLIC CLEARANCE RATE; QUINOXALINES; RABBITS; RATS; TISSUE DISTRIBUTION; VITREOUS BODY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036210727     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.4.421     Document Type: Article

References (29)

1. Characterization of brimonidine metabolism with rabbit liver aldehyde oxidase
2. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits
3. Measurement of brimonidine concentrations in human plasma by a highly sensitive gas chromatography/mass spectrometric assay
4. Brimonidine: A review of its pharmacological properties and clinical potential in the management of open·angle glaucoma and ocular hypertension
5. Preclinical safety profile of brimonidine
6. 2-adrenoceptor agonists in glaucoma
7. Corneal penetration and ocular bioavailability of drugs
8. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes
9. Changing therapeutic paradigms in glaucoma management
10. 2-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia
11. 2-Adrenergic receptors in rat and rabbit eye: A tritium-sensitive film autoradiography
12. Mechanisms of corneal drug penetration I: In vivo and in vitro kinetics
13. 2-adrenergic receptor agonist brimonidine in blood serum and aqueous humor of the eye
14. Vitreous concentrations of topically applied brimonidine tartrate
15. Neuroprotective effect of ocular hypotensive agent brimonidine
16. Topical ocular drug delivery: Recent developments and future challenges
17. 2-adrenergic receptors in the human eye
18. Ocular pharmacokinetics
19. The effect of ocular pigmentation on intraocular pressure response to timolol
20. Pharmacokinetics in ocular delivery
21. The effect of melanin binding on brimonidine disposition in rabbit eyes
22. Pharmacokinetic and pharmacodynamic correlations for ophthalmic drugs
23. Calculating the area of the curve and its standard error in single tissue sampling compartments
24. Effects of brimonidine on aqueous humor dynamics in human eyes
25. 2-adrenergic receptors in neuroprotection and glaucoma
26. From the lab to the clinic: Activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury
27. 2-Adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration
28. Physicochemical factors associated with binding and retention of compounds in ocular melanin of rats: Correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses